Vanda Pharmaceuticals Inc (VNDA): Major Improvements, Worth A Look

Vanda Pharmaceuticals Inc (NASDAQ:VNDA) concluded the trading at $4.88 on Friday, May 03, with a rise of 4.27% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $4.68. Company’s P/E ratio for the trailing 12 months is 111.67. Considering stock’s 52-week price range provides that VNDA hit a high price of $7.00 and saw its price falling to a low level of $3.30 during that period. Over a period of past 1-month, stock came subtracting -0.81% in its value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

With its current market valuation of $284.02 million. Analysts are in estimates of 0.05 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -0.06 for current year with estimates of that growing to -0.33 in next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 48.5M. They suggested that in the process company could generate revenue of as low as 48.5M which could climb up to 48.5M to hit a high. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 194.5M in current fiscal year, which will be 1.00% more from revenue generated by the company last year.

In contrast, when we review VNDA stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 50% Buy for it.

Digging deeper we become aware of the PEG ratio of the VNDA stock which is currently positioned at 3.09. It further provides that stock’s current price level is 6.18% away from its 20-day simple moving average and is 13.18% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 57.69 while volatility remained at 4.11% over the past week which changes to 5.29% when measuring it over the past month. Beta is valued at 0.70, while measure of average true range or ATR is currently at 0.28.

Having a second look at Vanda Pharmaceuticals Inc (NASDAQ:VNDA) provides that stock’s average daily trading volume for 3 months was 2.38 million. Number of outstanding shares of the stock stood at 57.53 million.

The percentage of outstanding shares held by the insiders is 5.26% while it is 86.00% for the institutional holders. Addition of 15.64% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Most Popular